Literature DB >> 2885881

Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants.

P Mason, J Skinner, D Luttinger.   

Abstract

The effects of mianserin, trazodone, amoxapine, maprotiline, and doxepin were assessed in punishment and pentylenetetrazol drug discrimination paradigms. These two procedures are used to identify antianxiety activity in rats. In the punishment procedure, misanserin produced an inverse dose-related increase in punished responding. The magnitude of the increase in punished responding with mianserin was comparable to that observed with the anxiolytic, buspirone. This effect was not observed with any of the other antidepressants tested. None of the antidepressants were found to be active in antagonizing the discriminative stimulus effects of pentylenetetrazol. In fact, at high doses there was a suggestion that the antidepressants may generalize to the pentylenetetrazol discriminative stimulus. Therefore, several antidepressants with purported clinical antianxiety activity, were not active in two procedures that detect antianxiety activity in rats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885881     DOI: 10.1007/bf00215475

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

1.  The clinical distinction between anxiety and depression.

Authors:  M Hamilton
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Generalization and antagonism studies with convulsant, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline.

Authors:  G T Shearman; H Lal
Journal:  Neuropharmacology       Date:  1980-05       Impact factor: 5.250

3.  Mianserin and doxepin in the treatment of outpatient depression with anxiety.

Authors:  M C Khan; E H Bennie; S M Stulemeijer; M A Ravens
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Observations on the relationship between anxiety and depressive symptoms during the course of depressive illnesses.

Authors:  G F Russell; P De Silva
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  The place of anxiety in depressive symptomatology.

Authors:  D Widlocher; Y Lecrubier; Y Le Goc
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  5 in total
  5 in total

1.  Effects of chlordiazepoxide, pentobarbital, buspirone, chlorpromazine, and morphine in the stretched attend posture (SAP) test.

Authors:  G T Pollard; J L Howard
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.

Authors:  T Paslawski; D Treit; G B Baker; M George; R T Coutts
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

Authors:  G A Kennett; K Pittaway; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

5.  Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.

Authors:  Adjia Hamadjida; Stephen G Nuara; Jim C Gourdon; Philippe Huot
Journal:  J Neural Transm (Vienna)       Date:  2017-12-15       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.